Renal-cell carcinomas in end-stage kidneys: A clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma

International Journal of Surgical Pathology

Volumn 20, Issue 1, 2012, Pages 19-28

  Bhatnagar, Ramneesh ^a   Alexiev, Borislav A ^a  

^a UMMC ^*  (United States)

Author keywords

end stage kidney carcinomas

Indexed keywords

CALCIUM OXALATE; CYTOKERATIN 7; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORPHOLOGY; CANCER STAGING; CELL NUCLEUS; CELL VACUOLE; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CYTOARCHITECTURE; CYTOPLASM; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES, CYSTIC; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 84859384867     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896911414273     Document Type: Article

References (33)

1. Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis. 1995;26:1-12.
2. Bonsib SM. Renal cystic disease and renal neoplasms: a mini review. Clin J Am Soc Nephrol. 2009;4:1998-2007.
3. Hughson MD, Meloni AM, Silva FG, Sandberg AA. Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings. Cancer Genet Cytogenet. 1996;89:65-68. (Pubitemid 26243660)
4. Hoshida Y, Nakanishi H, Shin M, Satoh T, Hanai J, Aozasa K. Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations. Transplantation. 1999;68:385-390. (Pubitemid 29384106)
5. Savaj S, Liakopoulos V, Ghareeb S, et al. Renal cell carcinoma in peritoneal dialysis patients. Int Urol Nephrol. 2003; 35:263-265. (Pubitemid 38418229)
6. Denton MD, Magee CC, Ovuworie C, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002;61:2201-2209. (Pubitemid 34539338)
7. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med. 1986;110:592-601. (Pubitemid 16095579)
8. Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol. 1977;30:868-877. (Pubitemid 8194693)
9. Matson MA, Cohen EP. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore). 1990;69:217-226. (Pubitemid 20225989)
10. Farivar-Mohseni H, Perlmutter AE, Wilson S, Shingleton WB, Bigler SA, Fowler JE Jr. Renal cell carcinoma and end stage renal disease. J Urol. 2006;175:2018-2020.
11. Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J Urol. 2005;174:1749-1753. (Pubitemid 41546926)
12. Rivera M, Tickoo SK, Saqi A, Lin O. Cytologic findings of acquired cystic disease-associated renal cell carcinoma: a report of two cases. Diagn Cytopathol. 2008;36:344-347. (Pubitemid 351631362)
13. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153. (Pubitemid 43740182)
14. Sule N, Yakupoglu U, Shen SS, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29:443-451. (Pubitemid 40411174)
15. Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol. 2006;19:780-787. (Pubitemid 43780447)
16. Bostwick DG, Cheng L, eds. Urologic Surgical Pathology. 2nd ed. Philadelphia, PA: Mosby Elsevier; 2008.
17. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
18. Gobbo S, Eble JN, Maclennan GT, et al. Renal cell carcinoma with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol. 2008;32:1780-1786.
19. Rioux-Leclercq NC, Epstein JI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney. Arch Pathol Lab Med. 2003;127:E89-E92.
20. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004.
21. Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol. 2007;31:957-960. (Pubitemid 47165152)
22. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti III A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
23. Hughson MD, Schmidt L, Zbar B, et al. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol. 1996;7:2461-2468. (Pubitemid 27465954)
24. Klatte T, Said JW, Seligson DB, et al. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features J Urol. 2011;185:30-36.
25. Mai KT, Faraji H, Desantis D, Robertson SJ, Belanger EC, Levac J. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study. Virchows Arch. 2010;456:77-84.
26. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-544.
27. Dry SM, Renshaw AA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases. Arch Pathol Lab Med. 1998;122:260-261.
28. Zamin-Khameh N, Zhai Q, Truong LD. Renal cell carcinoma with calcium oxalate deposition: a distinct type of renal cell carcinoma within the spectrum of renal neoplasms associated with acquired cystic kidney disease. Pathol Case Rev. 2010;15:14-19.
29. Kovacs G. High frequency of papillary renal-cell tumours in end-stage kidneys: is there a molecular genetic explanation? Nephrol Dial Transplant. 1995;10:593-596.
30. Hes O, Sima R, Nemcova J, et al. End-stage kidney disease: gains of chromosome 7 and 17 and loss of Y chromosome in non-neoplastic tissue. Virchows Arch. 2008;453:313-319.
31. Hughson MD, Bigler S, Dickman K, Kovacs G. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol. 1999;12:301-309.
32. Kuroda N, Shiotsu T, Hes O, Michal M, Shuin T, Lee GH. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol. 2010;43: 231-234.
33. Curti BD. Renal cell carcinoma. JAMA. 2004;292:97-100.